Moncef Slaoui - 19 Jun 2024 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Director
Signature
/s/ Grant Levine, attorney-in-fact
Issuer symbol
ARCT
Transactions as of
19 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 21:30:44 UTC
Next filing
11 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Stock option (right to buy) Award $0 +15,000 $0.000000 15,000 19 Jun 2024 Common Stock 15,000 $25.96 Direct F1
transaction ARCT Stock option (right to buy) Award $0 +14,794 $0.000000 14,794 19 Jun 2024 Common Stock 14,794 $25.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors.
F2 Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board.